World Bank Bars Indian Drug Firms For Price-Fixing
Two India-based pharmaceutical companies will be ineligible to be awarded World Bank-financed contracts after an investigation revealed that they had engaged in collusive practices in connection with a reproductive and child...To view the full article, register now.
Already a subscriber? Click here to view full article